Literature DB >> 28941123

Renal involvement in primary Sjögren's syndrome: A retrospective study of 103 biopsy-proven cases from a single center in China.

Hua-Xia Yang1, Jing Wang2, Yu-Bing Wen2, Yun-Yun Fei1, Meng-Di Jiang1, Meng-Yu Zhou2, Wen Zhang1, Hang Li2, Xue-Mei Li2, Feng-Chun Zhang1, Xue-Wang Li2, Xuan Zhang1, Li-Meng Chen2.   

Abstract

AIM: To retrospectively investigate the features of renal involvements in patients with primary Sjögren's syndrome (pSS) with biopsy results.
METHODS: A total of 2096 pSS inpatients at Peking Union Medical College Hospital in China from 2005 to 2015 were identified. Patients with biopsy-proven renal involvement (SS-renal) and matched controls (SS-only) were recruited. The clinical and pathologic features as well as treatments and outcomes were systematically analyzed.
RESULTS: One hundred and three pSS nephritis (inpatients had biopsy-proven renal involvement. Tubulointerstitial 53, 51.5%) was the prominent pathologic pattern with glomerulonephritis (GN) present in 50 (48.5%) of the renal lesions. The patterns of GN lesions included membranous nephropathy (37, 35.9%), mesangial proliferative glomerulonephritis (six, 5.8%) or immunoglobulin A nephropathy (three, 2.9%), minimal change disease (four, 3.9%) and focal segmental glomerulosclerosis (three, 2.9%). Compared to SS-only patients, SS-renal patients had fewer dry eyes and positive objective xerostomia (P < 0.05). They presented with a significantly lower incidence of interstitial lung disease (ILD), leukocytopenia and elevated immunoglobulin G levels (P < 0.05). They received a larger initial dosage of corticosteroid and had a higher mortality rate (P < 0.05).
CONCLUSION: This Chinese SS-renal population with biopsy results has diverse pathologic patterns and distinct clinical features. They are characterized with prominent renal-associated and mild SS-associated features. They received more vigorous treatment but had poorer prognosis.
© 2017 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  biopsy; primary Sjögren's syndrome; renal involvement

Mesh:

Substances:

Year:  2017        PMID: 28941123     DOI: 10.1111/1756-185X.13182

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  14 in total

1.  Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary sjogren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian Society of Rheumatology (articular, pulmonary and renal).

Authors:  Virginia Fernandes Moça Trevisani; Alisson Pugliesi; Sandra Gofinet Pasoto; Maria Lucia Lemos Lopes; Lissiane Karine Noronha Guedes; Samira Tatiyama Miyamoto; Marilena Leal Mesquita Silvestre Fernandes; Sonia Cristina de Magalhães Souza Fialho; Aysa César Pinheiro; Laura Caldas Dos Santos; Simone Appenzeller; Tania Fidelix; Sandra Lúcia Euzébio Ribeiro; Danielle Christinne Soares Egypto de Brito; Tatiana Nayara Libório-Kimura; Maria Carmen Lopes Ferreira Silva Santos; Diego Ustárroz Cantali; Juliana D'Agostino Gennari; Vinicius Tassoni Civile; Ana Carolina Pereira Nunes Pinto; César Ramos Rocha-Filho; Fabiola Reis Oliveira; Aline Pereira da Rocha; Valeria Valim
Journal:  Adv Rheumatol       Date:  2022-06-01

2.  Membranous nephropathy with masked polyclonal IgG deposits associated with primary Sjögren's syndrome.

Authors:  Kiyotaka Nagahama; Aya Isomura; Hiroaki Shimoyamada; Shintaro Masuko; Sachiko Shimoda; Miho Karube; Yoshinori Komagata; Shinya Kaname; Junji Shibahara
Journal:  CEN Case Rep       Date:  2020-08-07

Review 3.  Nephrological disorders and neurological involvement in pediatric primary Sjogren syndrome:a case report and review of literature.

Authors:  Jingya Zhao; Qin Chen; Yunyun Zhu; Meng Zhao; Jun Liu; Zhenzhong Zhang; Xiaoting Gong
Journal:  Pediatr Rheumatol Online J       Date:  2020-05-24       Impact factor: 3.054

4.  Sjögren's Syndrome: Animal Models, Etiology, Pathogenesis, Clinical Subtypes, and Diagnosis.

Authors:  Long Shen; Jing He; Jill M Kramer; Vatinee Y Bunya
Journal:  J Immunol Res       Date:  2019-05-20       Impact factor: 4.818

5.  Clinical features and potential relevant factors of renal involvement in primary Sjögren's syndrome.

Authors:  Jing Luo; Shihao Xu; Yinqiu Lv; Xinshi Huang; Huxiang Zhang; Xiaochun Zhu; Xiaobing Wang
Journal:  Int J Rheum Dis       Date:  2018-11-08       Impact factor: 2.454

6.  Renal tubular acidosis as the initial presentation of Sjögren's syndrome.

Authors:  Karen Ho; Pouneh Dokouhaki; Mark McIsaac; Bhanu Prasad
Journal:  BMJ Case Rep       Date:  2019-08-13

7.  Nephrotic Syndrome due to Focal Segmental Glomerulosclerosis Complicating Sjögren's Syndrome: A Case Report and Literature Review.

Authors:  Shigekazu Kurihara; Makoto Harada; Tohru Ichikawa; Takashi Ehara; Mamoru Kobayashi
Journal:  Case Rep Rheumatol       Date:  2019-08-15

8.  Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren's Syndrome-Like Disease.

Authors:  Ghada Abughanam; Osama A Elkashty; Younan Liu; Mohammed O Bakkar; Simon D Tran
Journal:  Int J Mol Sci       Date:  2019-09-25       Impact factor: 5.923

Review 9.  Biomarkers and Diagnostic Testing for Renal Disease in Sjogren's Syndrome.

Authors:  Giacomo Ramponi; Marco Folci; Salvatore Badalamenti; Claudio Angelini; Enrico Brunetta
Journal:  Front Immunol       Date:  2020-09-17       Impact factor: 7.561

10.  Primary Sjögren syndrome-associated acute interstitial nephritis and type 3 renal tubular acidosis in a patient with thin basement membrane nephropathy: A case report.

Authors:  Tian Du; Xiaohang Liu; Wei Ye; Wenling Ye; Chao Li
Journal:  Medicine (Baltimore)       Date:  2020-08-07       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.